{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:24:36Z","timestamp":1770816276617,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12936-019-2640-2","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T09:02:26Z","timestamp":1547715746000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam"],"prefix":"10.1186","volume":"18","author":[{"given":"Nguyen Chinh","family":"Phong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Chavchich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huynh Hong","family":"Quang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Ngoc","family":"San","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey W.","family":"Birrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilin","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Duc","family":"Manh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Edstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"key":"2640_CR1","volume-title":"World malaria report 2017","author":"WHO","year":"2017","unstructured":"WHO. World malaria report 2017. Geneva: World Health Organization; 2017."},{"key":"2640_CR2","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/j.1365-3156.2006.01690.x","volume":"11","author":"MB Denis","year":"2006","unstructured":"Denis MB, Tsuyuoka R, Poravuth Y, Narann TS, Seila S, Lim C, et al. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Trop Med Int Health. 2006;11:1360\u20136.","journal-title":"Trop Med Int Health."},{"key":"2640_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"2640_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1475-2875-8-10","volume":"8","author":"WO Rogers","year":"2009","unstructured":"Rogers WO, Sem R, Tero T, Chim P, Lim P, Muth S, et al. Failure of artesunate\u2013mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar J. 2009;8:10.","journal-title":"Malar J."},{"key":"2640_CR5","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1056\/NEJMc1403007","volume":"371","author":"D Saunders","year":"2014","unstructured":"Saunders D, Vanachayangkul P, Lon C, U.S. Army Military Malaria Research Program, National Center for Parasitology, Entomology, and Malaria Control (CNM), Royal Cambodian Armed Forces. Dihydroartemisinin\u2013piperaquine failure in Cambodia. N Engl J Med. 2014;371:484\u20135.","journal-title":"N Engl J Med."},{"key":"2640_CR6","volume-title":"Artemisinin and artemisinin-based combination therapy resistance. Status report. April, 2017","author":"WHO","year":"2017","unstructured":"WHO. Artemisinin and artemisinin-based combination therapy resistance. Status report. April, 2017. Geneva: World Health Organization; 2017."},{"key":"2640_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12936-017-1680-8","volume":"16","author":"NV Thanh","year":"2017","unstructured":"Thanh NV, Thuy-Nhien N, Tuyen NTK, Tong NT, Nha-Ca NT, Dong LT, et al. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin\u2013piperaquine in the south of Vietnam. Malar J. 2017;16:27.","journal-title":"Malar J."},{"key":"2640_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4269\/ajtmh.2007.77.79","volume":"77","author":"RN Price","year":"2007","unstructured":"Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007;77:79\u201387.","journal-title":"Am J Trop Med Hyg"},{"key":"2640_CR9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1128\/CMR.00008-09","volume":"22","author":"JK Baird","year":"2009","unstructured":"Baird JK. Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev. 2009;22:508\u201334.","journal-title":"Clin Microbiol Rev"},{"key":"2640_CR10","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1046\/j.1365-3156.2002.00948.x","volume":"7","author":"GT Phan","year":"2002","unstructured":"Phan GT, de Vries PJ, Tran BQ, Le HQ, Nguyen NV, Nguyen TV, et al. Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam. Trop Med Int Health. 2002;7:858\u201364.","journal-title":"Trop Med Int Health."},{"key":"2640_CR11","doi-asserted-by":"publisher","first-page":"7411","DOI":"10.1128\/AAC.00791-15","volume":"59","author":"PV Thanh","year":"2015","unstructured":"Thanh PV, Hong NV, Van NV, Louisa M, Baird K, Xa NX, et al. Confirmed Plasmodium vivax resistance to chloroquine in central Vietnam. Antimicrob Agents Chemother. 2015;59:7411\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2640_CR12","doi-asserted-by":"publisher","first-page":"879","DOI":"10.4269\/ajtmh.15-0740","volume":"94","author":"PD Thuan","year":"2016","unstructured":"Thuan PD, Ca NTN, Toi PV, Nhien NTT, Thanh NV, Anh ND, et al. A randomized comparison of chloroquine versus dihydroartemisinin\u2013piperaquine for the treatment of Plasmodium vivax infection in Vietnam. Am J Trop Med Hyg. 2016;94:879\u201385.","journal-title":"Am J Trop Med Hyg"},{"key":"2640_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1475-2875-4-58","volume":"4","author":"A Erhart","year":"2005","unstructured":"Erhart A, Ngo DT, Phan VK, Tinh TT, Overmeir CV, Speybroeck N, et al. Epidemiology of forest malaria in central Vietnam: a large scale cross-sectional survey. Malar J. 2005;4:58.","journal-title":"Malar J."},{"key":"2640_CR14","doi-asserted-by":"publisher","first-page":"652","DOI":"10.4269\/ajtmh.2008.79.652","volume":"79","author":"NH Sanh","year":"2008","unstructured":"Sanh NH, Van Dung N, Thanh NX, Trung TN, Van Co T, Cooper RD. Forest malaria in central Vietnam. Am J Trop Med Hyg. 2008;79:652\u20134.","journal-title":"Am J Trop Med Hyg"},{"key":"2640_CR15","volume-title":"Methods for surveillance of antimalarial drug efficacy","author":"WHO","year":"2009","unstructured":"WHO. Methods for surveillance of antimalarial drug efficacy. Geneva: World Health Organization; 2009."},{"key":"2640_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2165\/00003088-199937020-00002","volume":"37","author":"NJ White","year":"1999","unstructured":"White NJ, van Vugt M, Ezzet F. Clinical pharmacokinetics and pharmaco-dynamics and pharmacodynamics of artemether\u2013lumefantrine. Clin Pharmacokinet. 1999;37:105\u201325.","journal-title":"Clin Pharmacokinet"},{"key":"2640_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1179\/000349803125002977","volume":"97","author":"D Padley","year":"2003","unstructured":"Padley D, Moody AH, Chiodini PL, Saldanha J. Use of a rapid, single-round, multiplex PCR to detect malaria species and identify species present. Ann Trop Med Parasitol. 2003;97:131\u20137.","journal-title":"Ann Trop Med Parasitol"},{"key":"2640_CR18","volume-title":"Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations","author":"WHO","year":"2008","unstructured":"WHO. Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. Geneva: World Health Organization; 2008."},{"key":"2640_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.4269\/ajtmh.1999.60.547","volume":"60","author":"R Price","year":"1999","unstructured":"Price R, van Vugt M, Phaipun L, Luxemburger C, Simpson J, McGready R, et al. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg. 1999;60:547\u201355.","journal-title":"Am J Trop Med Hyg"},{"key":"2640_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"2640_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","volume":"17","author":"R Amato","year":"2017","unstructured":"Amato R, Lim P, Miotto O, Amaratunga C, Dek D, Pearson RD, et al. Genetic markers associated with dihydroartemisinin\u2013piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype\u2013phenotype association study. Lancet Infect Dis. 2017;17:164\u201373.","journal-title":"Lancet Infect Dis."},{"key":"2640_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","volume":"17","author":"B Witkowski","year":"2017","unstructured":"Witkowski B, Duru V, Khim N, Ross LS, Saintpierre B, Beghain J, et al. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype\u2013genotype association study. Lancet Infect Dis. 2017;17:174\u201383.","journal-title":"Lancet Infect Dis."},{"key":"2640_CR23","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1128\/AAC.02838-15","volume":"60","author":"M Chavchich","year":"2016","unstructured":"Chavchich M, Van Breda K, Rowcliffe K, Diagana TT, Edstein MD. The spiroindolone KAE609 does not induce dormant ring stages in Plasmodium falciparum parasites. Antimicrob Agents Chemother. 2016;60:5167\u201374.","journal-title":"Antimicrob Agents Chemother"},{"key":"2640_CR24","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/AAC.16.6.710","volume":"16","author":"RE Desjardins","year":"1979","unstructured":"Desjardins RE, Canfield CJ, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979;16:710\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"2640_CR25","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1128\/AAC.03066-15","volume":"60","author":"M Chavchich","year":"2016","unstructured":"Chavchich M, Birrell GW, Ager AL, MacKenzie DO, Heffernan GD, Schiehser GA, et al. Lead selection of the new aminomethylphenol, JPC-3210 for malaria treatment and prevention. Antimicrob Agents Chemother. 2016;60:3115\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"2640_CR26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","volume":"13","author":"B Witkowski","year":"2013","unstructured":"Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, et al. Novel phenotypic assays for the detection of artemisinin resistant Plasmodium falciparum malaria in Cambodia: in vitro and ex vivo drug-response studies. Lancet Infect Dis. 2013;13:1043\u20139.","journal-title":"Lancet Infect Dis"},{"key":"2640_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12916-015-0539-5","volume":"13","author":"V Duru","year":"2015","unstructured":"Duru V, Khim N, Leang R, Kim S, Domergue A, Kloeung N, et al. Plasmodium falciparum dihydroartemisinin\u2013piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations. BMC Med. 2015;13:305\u201316.","journal-title":"BMC Med."},{"key":"2640_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jchromb.2008.10.021","volume":"876","author":"N Lindegardh","year":"2008","unstructured":"Lindegardh N, Hanpithakpong W, Kamanikom B, Singhasivanon P, Socheat D, Yi P, et al. Major pitfalls in the measurement of artemisinin derivatives in plasma in clinical studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;876:54\u201360.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"2640_CR29","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1128\/AAC.02362-14","volume":"58","author":"C Lourens","year":"2014","unstructured":"Lourens C, Lindegardh N, Barnes KI, Guerin PJ, Sibley CH, White NJ, et al. Benefits of a pharmacology antimalarial reference standard and proficiency testing program provided by the Worldwide Antimalarial Resistance Network (WWARN). Antimicrob Agents Chemother. 2014;58:3889\u201394.","journal-title":"Antimicrob Agents Chemother"},{"key":"2640_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/1475-2875-10-339","volume":"10","author":"JA Flegg","year":"2011","unstructured":"Flegg JA, Guerin PJ, White NJ, Stepniewska K. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J. 2011;10:339.","journal-title":"Malar J."},{"key":"2640_CR31","first-page":"136","volume":"1","author":"J Lewis","year":"2006","unstructured":"Lewis J, Sauro J. When 100% really isn\u2019t 100%: improving the accuracy of small-sample estimates of completion rates. J Usab Studies. 2006;1:136\u201350.","journal-title":"J Usab Studies."},{"key":"2640_CR32","first-page":"119","volume":"52","author":"A Agresti","year":"1998","unstructured":"Agresti A, Coull B. Approximate is better than \u2018exact\u2019 for interval estimation of binomial proportions. Am Stat. 1998;52:119\u201326.","journal-title":"Am Stat"},{"key":"2640_CR33","volume-title":"Theorie analytique des probabilitites","author":"PS Laplace","year":"1812","unstructured":"Laplace PS. Theorie analytique des probabilitites. Paris: Courcier; 1812."},{"key":"2640_CR34","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","volume":"347","author":"J Straimer","year":"2015","unstructured":"Straimer J, Gn\u00e4dig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, et al. Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015;347:428\u201331.","journal-title":"Science."},{"key":"2640_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1475-2875-9-181","volume":"9","author":"NV Thanh","year":"2010","unstructured":"Thanh NV, Toan TQ, Cowman AF, Casey GJ, Phuc BQ, Tien NT, et al. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998\u20132009. Malar J. 2010;9:181.","journal-title":"Malar J."},{"key":"2640_CR36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4269\/ajtmh.1996.55.254","volume":"55","author":"P Ringwald","year":"1996","unstructured":"Ringwald P, Bickii J, Basco LK. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am J Trop Med Hyg. 1996;55:254\u20138.","journal-title":"Am J Trop Med Hyg."},{"key":"2640_CR37","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.4269\/ajtmh.2010.10-0339","volume":"83","author":"M Mungthin","year":"2010","unstructured":"Mungthin M, Khositnithikul R, Sitthichot N, Suwandittakul N, Wattanaveeradej V, Ward SA, et al. Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in Thai isolates of Plasmodium falciparum. Am J Trop Med Hyg. 2010;83:1005\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"2640_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/1475-2875-10-268","volume":"10","author":"B Pradines","year":"2011","unstructured":"Pradines B, Bertaux L, Pomares C, Delaunay P, Marty P. Reduced in vitro susceptibility to artemisinin derivatives associated with multi-resistance in a traveller returning from South-East Asia. Malar J. 2011;10:268.","journal-title":"Malar J."},{"key":"2640_CR39","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/jac\/dkx431","volume":"73","author":"HM Staines","year":"2018","unstructured":"Staines HM, Burrow R, Teo BH, Chis Ster I, Kremsner PG, Krishna S. Clinical implications of Plasmodium resistance to atovaquone\/proguanil: a systematic review and meta-analysis. J Antimicrob Chemother. 2018;73:581\u201395.","journal-title":"J Antimicrob Chemother"},{"key":"2640_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12936-015-0586-6","volume":"14","author":"A Pascual","year":"2015","unstructured":"Pascual A, Madamet M, Briolant S, Gaillard T, Amalvict R, Benoit N, et al. Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine. Malar J. 2015;14:49.","journal-title":"Malar J."},{"key":"2640_CR41","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1128\/AAC.01868-12","volume":"57","author":"B Witkowski","year":"2013","unstructured":"Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeung N, et al. Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob Agents Chemother. 2013;57:914\u201323.","journal-title":"Antimicrob Agents Chemother"},{"key":"2640_CR42","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00228-008-0506-6","volume":"64","author":"LT Diem Thuy","year":"2008","unstructured":"Diem Thuy LT, Ngoc Hung L, Danh PT, Na-Bangchang K. Absence of time-dependent artesunate pharmacokinetics in healthy subjects during 5-day oral administration. Eur J Clin Pharmacol. 2008;64:993\u20138.","journal-title":"Eur J Clin Pharmacol"},{"key":"2640_CR43","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1128\/AAC.00365-11","volume":"55","author":"NT Chinh","year":"2011","unstructured":"Chinh NT, Quang NN, Anh CX, Thanh NX, Dai B, Birrell GW, et al. The pharmacokinetics and ex vivo antimalarial activity of artesunate plus azithromycin in healthy volunteers. Antimicrob Agents Chemother. 2011;55:4412\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"2640_CR44","doi-asserted-by":"publisher","first-page":"5484","DOI":"10.1128\/AAC.00044-12","volume":"56","author":"D Saunders","year":"2012","unstructured":"Saunders D, Khemawoot P, Vanachayangkul P, Siripokasupkul R, Bethell D, Tyner S, Se Y, et al. Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia. Antimicrob Agents Chemother. 2012;56:5484\u201393.","journal-title":"Antimicrob Agents Chemother"},{"key":"2640_CR45","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12936-018-2278-5","volume":"17","author":"JP Lohy Das","year":"2018","unstructured":"Lohy Das JP, Kyaw MP, Nyunt MH, Chit K, Aye KH, Aye MM, et al. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar. Malar J. 2018;17:126.","journal-title":"Malar J."},{"key":"2640_CR46","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1046\/j.1365-2125.1998.00830.x","volume":"46","author":"F Ezzet","year":"1998","unstructured":"Ezzet F, Mull R, Karbwang J. Population pharmacokinetics and therapeutic response of CGP 56697 (artemether\u2009+\u2009benflumetol) in malaria patients. Br J Clin Pharmacol. 1998;46:553\u201361.","journal-title":"Br J Clin Pharmacol"},{"key":"2640_CR47","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/j.1365-3156.2006.01739.x","volume":"11","author":"MB Denis","year":"2006","unstructured":"Denis MB, Tsuyuoka R, Lim P, et al. Efficacy of artemether\u2013lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Trop Med Int Health. 2006;11:1800\u20137.","journal-title":"Trop Med Int Health."},{"key":"2640_CR48","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1086\/503423","volume":"42","author":"RN Price","year":"2006","unstructured":"Price RN, Uhlemann AC, van Vugt M, Brockman A, Hutagalung R, Nair S, et al. Molecular and pharmacological determinants of the therapeutic response to artemether\u2013lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin Infect Dis. 2006;42:1570\u20137.","journal-title":"Clin Infect Dis"},{"key":"2640_CR49","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1128\/AAC.05136-11","volume":"55","author":"S Salman","year":"2011","unstructured":"Salman S, Page-Sharp M, Griffin S, Kose K, Siba PM, Ilett KF, et al. Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria. Antimicrob Agents Chemother. 2011;55:5306\u201313.","journal-title":"Antimicrob Agents Chemother"},{"key":"2640_CR50","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1128\/AAC.48.11.4075-4083.2004","volume":"48","author":"JK Baird","year":"2004","unstructured":"Baird JK. Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother. 2004;48:4075\u201383.","journal-title":"Antimicrob Agents Chemother"},{"key":"2640_CR51","doi-asserted-by":"publisher","first-page":"621","DOI":"10.4269\/ajtmh.1997.56.621","volume":"56","author":"JK Baird","year":"1997","unstructured":"Baird JK, Leksana B, Masbar S, Fryauff DJ, Sutanihardja MA, Suradi, et al. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am J Trop Med Hyg. 1997;56:621\u20136.","journal-title":"Am J Trop Med Hyg."},{"key":"2640_CR52","doi-asserted-by":"publisher","first-page":"513","DOI":"10.4269\/ajtmh.1998.59.513","volume":"59","author":"DJ Fryauff","year":"1998","unstructured":"Fryauff DJ, Tuti S, Mardi A, Masbar S, Patipelohi R, Leksana B, et al. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. Am J Trop Med Hyg. 1998;59:513\u20138.","journal-title":"Am J Trop Med Hyg."},{"key":"2640_CR53","first-page":"237","volume":"37","author":"L Rombo","year":"1986","unstructured":"Rombo L, Kihamia CM, Mahikwano LF, Ericsson O, Sj\u00f6qvist F. Concentrations of chloroquine and desethylchloroquine in capillary blood dried on filter paper during and after treatment of Tanzanian children infected with Plasmodium falciparum. Trop Med Parasitol. 1986;37:237\u201340.","journal-title":"Trop Med Parasitol."},{"key":"2640_CR54","first-page":"197","volume":"67","author":"U Hellgren","year":"1989","unstructured":"Hellgren U, Kihamia CM, Mahikwano LF, Bj\u00f6rkman A, Eriksson O, Rombo L. Response of Plasmodium falciparum to chloroquine treatment: relation to whole blood concentrations of chloroquine and desethylchloroquine. Bull World Health Organ. 1989;67:197\u2013202.","journal-title":"Bull World Health Organ"},{"key":"2640_CR55","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12936-018-2372-8","volume":"17","author":"SM Goldlust","year":"2018","unstructured":"Goldlust SM, Thuan PD, Giang DDH, Thang ND, Thwaites GE, Farrar J, et al. The decline of malaria in Vietnam, 1991\u20132014. Malar J. 2018;17:226.","journal-title":"Malar J."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-019-2640-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-019-2640-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-019-2640-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:06:35Z","timestamp":1579219595000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-019-2640-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2640"],"URL":"https:\/\/doi.org\/10.1186\/s12936-019-2640-2","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,17]]},"assertion":[{"value":"28 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"10"}}